EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

PET imaging of synaptic density in Parkinsonian disorders

Sarah L Martin iD, Carme Uribe iD, Antonio P Strafella

Journal of Neuroscience Research · 2024-03 · 102 (3)

DOI: 10.1002/jnr.25253 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Neuroscience Research, online erschienen am 10.10.2023. Verfasst von Sarah L Martin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Brain Health Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Parkinsonian Disorders, Parkinson Disease. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: CIHR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Synaptic dysfunction and altered synaptic pruning are present in people with Parkinsonian disorders. Dopamine loss and alpha‐synuclein accumulation, two hallmarks of Parkinson's disease (PD) pathology, contribute to synaptic dysfunction and reduced synaptic density in PD. Atypical Parkinsonian disorders are likely to have unique spatiotemporal patterns of synaptic density, differentiating them from PD. Therefore, quantification of synaptic density has the potential to support diagnoses, monitor disease progression, and treatment efficacy. Novel radiotracers for positron emission tomography which target the presynaptic vesicle protein SV2A have been developed to quantify presynaptic density. The radiotracers have successfully investigated synaptic density in preclinical models of PD and people with Parkinsonian disorders. Therefore, this review will summarize the preclinical and clinical utilization of SV2A radiotracers in people with Parkinsonian disorders. We will evaluate how SV2A abundance is associated with other imaging modalities and the considerations for interpreting SV2A in Parkinsonian pathology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinsonian DisordersParkinson DiseaseHumansPositron-Emission TomographySynapsesDopamineBrain

Stichwörter der Autor:innen

Parkinson's diseaseSV2ASynVesT-1UCB-Jcorticobasal degenerationmultiple systems atrophyprogressive supranuclear palsy

Substanzen

Dopamine

Autor:innen und Institutionen

  • Brain Health Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
  • Unitat de Psicologia Medica, Departament de Medicina, Institute of Neuroscience, Universitat de Barcelona, Barcelona, Spain.
  • Edmond J. Safra Parkinson Disease Program, Neurology Division, Toronto Western Hospital & Krembil Brain Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada.

ORCID-Profile: Sarah L Martin, Carme Uribe

Förderung

  • CIHR

Zitieren

APA

Martin, S. L., Uribe, C., & Strafella, A. P. (2024). PET imaging of synaptic density in Parkinsonian disorders. Journal of Neuroscience Research, 102(3). https://doi.org/10.1002/jnr.25253

Vancouver

Martin SL, Uribe C, Strafella AP. PET imaging of synaptic density in Parkinsonian disorders. Journal of Neuroscience Research. 2024;102(3). doi:10.1002/jnr.25253

BibTeX
@article{Martin2024,
  author = {Martin, Sarah L and Uribe, Carme and Strafella, Antonio P},
  title = {PET imaging of synaptic density in Parkinsonian disorders},
  journal = {Journal of Neuroscience Research},
  year = {2024},
  volume = {102},
  number = {3},
  doi = {10.1002/jnr.25253}
}
Kostenlos starten →